Company Data
Design Therapeutics Inc.
Ticker
DSGN
Current Price
$3.695 -7.86%
Market Cap
$209.8M
Price Target
Refer to Report
Volume
21.2K
52wk Range
$2.6 - $7.77
Overview
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.